Prognostic value of epigenetic markers for canine mast cell cancer.
Canine Mast cell tumors (MCTs) constitute approximately 21% of all canine skin tumors. Despite the use of comprehensive grading systems, biological aggressiveness is sometimes difficult to predict, therefore there is a need for better prognostic markers. Progression in various cancers involves DNA h...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0283616 |
| _version_ | 1797842898141577216 |
|---|---|
| author | Shahzar Syed Britta J Knight Geoffrey A Wood Brenda Lynn Coomber |
| author_facet | Shahzar Syed Britta J Knight Geoffrey A Wood Brenda Lynn Coomber |
| author_sort | Shahzar Syed |
| collection | DOAJ |
| description | Canine Mast cell tumors (MCTs) constitute approximately 21% of all canine skin tumors. Despite the use of comprehensive grading systems, biological aggressiveness is sometimes difficult to predict, therefore there is a need for better prognostic markers. Progression in various cancers involves DNA hypermethylation, hypomethylation and epigenetic enzyme dysregulation. Therefore, global levels of 5-methylcytosine, 5-hydroxymethylcytosine and associated enzymes DNMT1, and IDH1 expression may predict MCT aggressiveness. A tissue microarray (TMA) with cores from 244 different tumor samples from 189 dogs was immunolabelled and used to quantify the global DNA methylation and hydroxymethylation levels as well as the levels of the enzymes involved in DNA methylation and their relationship with canine MCT outcome. From the immunolabelled TMA, H-scores were generated using QuPath (v0.1.2) and analyzed with associated patient data. High 5MC and DNMT1, and low IDH1 levels were associated with poorer outcome when looking at all canine MCT cases. High 5MC levels showed significance for shorter disease-free interval (DFI) in subcutaneous cases and high 5MC levels showed poorer DFI and overall survival (OS) in cases with Kiupel's grading system high grade. Cases with grade II in Patnaik's grading system showed better DFI with low levels of DNMT1 and better OS with low levels of 5MC and 5HMC. High levels of DNMT1 staining were also associated with shorter DFI for dermal MCTs. For cases that received adjuvant therapy in addition to surgery, all parameters except IDH1 were significantly associated with OS. Therefore, there is potential for DNA methylation status and levels of enzymes associated with DNA methylation pathways to better predict outcome in canine MCT, and to possibly influence treatment decisions. |
| first_indexed | 2024-04-09T16:56:44Z |
| format | Article |
| id | doaj.art-29b4fb303ca548b9bb7d512aca4828a2 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-09T16:56:44Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-29b4fb303ca548b9bb7d512aca4828a22023-04-21T05:35:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183e028361610.1371/journal.pone.0283616Prognostic value of epigenetic markers for canine mast cell cancer.Shahzar SyedBritta J KnightGeoffrey A WoodBrenda Lynn CoomberCanine Mast cell tumors (MCTs) constitute approximately 21% of all canine skin tumors. Despite the use of comprehensive grading systems, biological aggressiveness is sometimes difficult to predict, therefore there is a need for better prognostic markers. Progression in various cancers involves DNA hypermethylation, hypomethylation and epigenetic enzyme dysregulation. Therefore, global levels of 5-methylcytosine, 5-hydroxymethylcytosine and associated enzymes DNMT1, and IDH1 expression may predict MCT aggressiveness. A tissue microarray (TMA) with cores from 244 different tumor samples from 189 dogs was immunolabelled and used to quantify the global DNA methylation and hydroxymethylation levels as well as the levels of the enzymes involved in DNA methylation and their relationship with canine MCT outcome. From the immunolabelled TMA, H-scores were generated using QuPath (v0.1.2) and analyzed with associated patient data. High 5MC and DNMT1, and low IDH1 levels were associated with poorer outcome when looking at all canine MCT cases. High 5MC levels showed significance for shorter disease-free interval (DFI) in subcutaneous cases and high 5MC levels showed poorer DFI and overall survival (OS) in cases with Kiupel's grading system high grade. Cases with grade II in Patnaik's grading system showed better DFI with low levels of DNMT1 and better OS with low levels of 5MC and 5HMC. High levels of DNMT1 staining were also associated with shorter DFI for dermal MCTs. For cases that received adjuvant therapy in addition to surgery, all parameters except IDH1 were significantly associated with OS. Therefore, there is potential for DNA methylation status and levels of enzymes associated with DNA methylation pathways to better predict outcome in canine MCT, and to possibly influence treatment decisions.https://doi.org/10.1371/journal.pone.0283616 |
| spellingShingle | Shahzar Syed Britta J Knight Geoffrey A Wood Brenda Lynn Coomber Prognostic value of epigenetic markers for canine mast cell cancer. PLoS ONE |
| title | Prognostic value of epigenetic markers for canine mast cell cancer. |
| title_full | Prognostic value of epigenetic markers for canine mast cell cancer. |
| title_fullStr | Prognostic value of epigenetic markers for canine mast cell cancer. |
| title_full_unstemmed | Prognostic value of epigenetic markers for canine mast cell cancer. |
| title_short | Prognostic value of epigenetic markers for canine mast cell cancer. |
| title_sort | prognostic value of epigenetic markers for canine mast cell cancer |
| url | https://doi.org/10.1371/journal.pone.0283616 |
| work_keys_str_mv | AT shahzarsyed prognosticvalueofepigeneticmarkersforcaninemastcellcancer AT brittajknight prognosticvalueofepigeneticmarkersforcaninemastcellcancer AT geoffreyawood prognosticvalueofepigeneticmarkersforcaninemastcellcancer AT brendalynncoomber prognosticvalueofepigeneticmarkersforcaninemastcellcancer |